Authors' Reply to Bonnet et al. "Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update"
- PMID: 33738758
- DOI: 10.1007/s40265-021-01495-0
Authors' Reply to Bonnet et al. "Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update"
Comment on
-
Comment on "Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update".Drugs. 2021 Apr;81(5):611-614. doi: 10.1007/s40265-021-01494-1. Epub 2021 Mar 18. Drugs. 2021. PMID: 33738757 Free PMC article. No abstract available.
References
-
- Bonnet U, McAnally H, Scherbaum N. Comment on 'abuse and misuse of pregabalin adn gabapentin: a systematic review update.' Drugs. 2021;2021:5. https://doi.org/10.1007/s40265-021-01494-1 . - DOI
-
- Bonnet U, Richter EL, Isbruch K, Scherbaum N. On the addictive power of gabapentinoids: a mini-review. PsychiatrDanub. 2018;30(2):142–9.
-
- Bonnet U, Scherbaum N. How addictive are gabapentin and pregabalin? A systematic review. EurNeuropsychopharmacol. 2017;27(12):1185–215. - DOI
-
- Bonnet U, Strasser JC, Scherbaum N. Screening for physical and behavioral dependence on non-opioid analgesics in a German elderly hospital population. Addict Behav. 2019;90:265–71. - DOI
-
- Evoy KE, Sadrameli S, Contreras J, Covvey JR, Peckham AM, Morrison MD. Abuse and misuse of pregabalin and gabapentin: a systematic review update. Drugs. 2021;81(1):125–56. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
